TI
ENZ

Trexquant Investment’s Enzo Biochem, Inc. ENZ Stock Holding History

Trexquant Investment’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-26,494
Closed -$145K – 1288
2018
Q1 		$145K Buy
+26,494
New +$187K 0.01% 989
2017
Q2 		– Sell
-13,740
Closed -$115K – 1235
2017
Q1 		$115K Buy
+13,740
New +$96.8K 0.01% 1025

Other funds holding ENZ

EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Trexquant Investment's ENZ Position: Q2 2018 in Review

Trexquant Investment sold out of Enzo Biochem, Inc. (ENZ) in Q2 2018, closing a stake of 26,494 shares — an estimated $145K sold.

Trexquant Investment first reported a position in ENZ in Q1 2017 and held it in 2 quarters. The position peaked at $145K in Q1 2018. 97 funds tracked by Wall St. Rank hold ENZ as of Q2 2018.

  • Trexquant Investment reported no remaining Enzo Biochem, Inc. position as of Q2 2018 after selling out during the quarter.
  • Trexquant Investment sold 26,494 Enzo Biochem, Inc. shares in Q2 2018, an estimated $145K.
  • Trexquant Investment first reported a position in Enzo Biochem, Inc. in Q1 2017 and held it in 2 quarters.
  • Trexquant Investment's Enzo Biochem, Inc. position peaked at $145K in Q1 2018.
  • 97 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2018.

Based on Trexquant Investment's 13F filing for Q2 2018, filed 7 Aug 2018.